Furthermore, imaging mass cytometry and multiplex immunohistochemistry allow for spatial validation of MHC expression at the protein level and can resolve the interplay between tumour cells and the immune microenvironment within defined anatomical contexts.68, 186. The gene discussed is HLA-C; the disease is neoplasm.